MAIA Biotechnology Inc. (NYSE AMERICAN: MAIA)
$3.74
-0.1350 ( -3.49% ) 80.2K
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Market Data
Open
$3.74
Previous close
$3.87
Volume
80.2K
Market cap
$79.19M
Day range
$3.65 - $3.90
52 week range
$0.82 - $5.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
8-k | 8K-related | 13 | Dec 21, 2023 |
3 | Insider transactions | 1 | Nov 20, 2023 |
8-k | 8K-related | 20 | Nov 17, 2023 |
8-k | 8K-related | 13 | Nov 16, 2023 |
8-k | 8K-related | 14 | Nov 15, 2023 |
8-k | 8K-related | 13 | Nov 13, 2023 |
8-k | 8K-related | 13 | Nov 07, 2023 |
10-q | Quarterly Reports | 52 | Nov 07, 2023 |